In a major leap for genomics research, data management, and next generation sequencing applications, Tahoe Therapeutics, the Arc Institute, and Biohub have announced a landmark collaboration to generate what is set to become the largest perturbation‑rich single‑cell...
Board Update We are excited to announce the appointment of two new Independent Directors. Following an extensive search and interviews with a number of highly qualified candidates InGeNA’s board are pleased to announce we have selected Monica Ferrie and Sandra...
2025’s Gene Therapy Breakthroughs Show the Future of Genomics in Action A new era of precision medicine is taking shape with remarkable speed, and few recent developments exemplify this better than the success of CRISPR-based and gene therapy interventions for rare...
InGeNA welcomes our new member VCGS VCGS (Victorian Clinical Genetics Services) are Australian experts in genetic testing. VCGS supports children, adults and families who are living with a genetic condition, or who want to understand their chance of developing one....
InGeNA welcomes our new partner CCRM InGeNA is proud to partner with CCRM Australia to strengthen the ecosystem delivering precision medicine and advanced therapies for Australians. At the heart of this partnership is a shared ambition: that every Australian has...
